drugset / Trial / NCT03512873
A Clinical Study of Tranilast in the Treatment of Scleredema Diabeticorum
NaSingle-groupOpen-labelTreatment
Summary
56 patients with scleredema diabeticorum will be selected to receive treatment of tranilast. After a period of time ,we can determine the efficacy of the drug by detecting the the thickness of skin before and after treatment.
Timeline
- Start
- 2018-06
- Primary completion
- 2020-06
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranilast | Small molecule | 0.1 g | — |